Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder.

被引:111
作者
Suzan, F
Ammor, M
Ribrag, V
机构
[1] Inst Gustave Roussy, F-94805 Villejuif, France
[2] Hop Kremlin Bicetre, F-94270 Le Kremlin Bicetre, France
关键词
D O I
10.1056/NEJM200109273451315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1000 / 1000
页数:1
相关论文
共 4 条
[1]  
Bermúdez A, 2000, HAEMATOLOGICA, V85, P894
[2]   Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].
Czuczman, MS ;
Grillo-López, AJ ;
White, CA ;
Saleh, M ;
Gordon, L ;
LoBuglio, AF ;
Jonas, C ;
Klippenstein, D ;
Dallaire, B ;
Varns, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276
[3]   Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. [J].
Dervite, I ;
Hober, D ;
Morel, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :68-69
[4]   Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab [J].
Sharma, VR ;
Fleming, DR ;
Slone, SP .
BLOOD, 2000, 96 (03) :1184-1186